Safety and Efficacy Study of Mini-Dose Glucagon (G-Pen Mini) in Patients With Type 1 Diabetes
NCT02081014
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
13
Enrollment
INDUSTRY
Sponsor class
Conditions
Hypoglycemia
Interventions
DRUG:
G-Pen Mini™ (glucagon injection)
Sponsor
Xeris Pharmaceuticals
Collaborators
[object Object]
[object Object]